CVE-2017-17674

moderate-risk
Published 2021-05-19

BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can be targeted, the system can be vulnerable to attacks such as system fingerprinting, internal port scanning, Server Side Request Forgery (SSRF), or remote code execution (RCE).

Do I need to act?

~
3.3% chance of exploitation in next 30 days
EPSS score — moderate exploit probability
-
Not on CISA KEV list
No confirmed active exploitation reported to CISA
?
Patch status unknown
Check vendor advisories for fix availability and mitigation guidance
9
CVSS 9.8/10 Critical
NETWORK / LOW complexity

Affected Products (1)

Remedy Mid-Tier

Affected Vendors

Bmc

References (8)

Product http://bmc.com
Product http://remedy.com
Release Notes https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-s...
Mailing List https://seclists.org/fulldisclosure/2017/Oct/52
Product http://bmc.com
Product http://remedy.com
Release Notes https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-s...
Mailing List https://seclists.org/fulldisclosure/2017/Oct/52
44
/ 100
moderate-risk
Severity 32/34 · Critical
Exploitability 7/34 · Low
Exposure 5/34 · Minimal